Published in
Elsevier, The Lancet, 10234(395), p. 1434-1443, 2020
DOI: 10.1016/s0140-6736(20)30556-0
Links
Tools
Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial
Journal article published in 2020 by
Vianney Tricou 
,
Xavier Sáez-Llorens,
Delia Yu,
Luis Rivera,
José Jimeno,
Ana Cecilia Villarreal,
Epiphany Dato,
Onix Saldaña de Suman,
Nathali Montenegro,
Rodrigo DeAntonio,
Sonia Mazara,
Maria Vargas,
Debbie Mendoza,
Martina Rauscher,
Manja Brose
and other authors.
,
Xavier Sáez-Llorens,
Delia Yu,
Luis Rivera,
José Jimeno,
Ana Cecilia Villarreal,
Epiphany Dato,
Onix Saldaña de Suman,
Nathali Montenegro,
Rodrigo DeAntonio,
Sonia Mazara,
Maria Vargas,
Debbie Mendoza,
Martina Rauscher,
Manja Brose
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 